Glaukos Corporation (NYSE:GKOS): Are Analysts Optimistic? [Yahoo! Finance]
Glaukos Corporation (GKOS)
Last glaukos corporation earnings: 2/27 04:15 pm
Check Earnings Report
US:NYSE Investor Relations:
investors.glaukos.com/investors/investor-overview/default.aspx
Company Research
Source: Yahoo! Finance
Glaukos Corporation, an ophthalmic pharmaceutical and medical technology company, develops therapies for the treatment of glaucoma, corneal disorders, and retinal diseases in the United States and internationally. The US$6.5b market-cap company posted a loss in its most recent financial year of US$146m and a latest trailing-twelve-month loss of US$88m shrinking the gap between loss and breakeven. The most pressing concern for investors is Glaukos' path to profitability – when will it breakeven? We've put together a brief outline of industry analyst expectations for the company, its year of breakeven and its implied growth rate. This technology could replace computers: discover the 20 stocks are working to make quantum computing a reality. Glaukos is bordering on breakeven, according to the 15 American Medical Equipment analysts. They expect the company to post a final loss in 2026, before turning a profit of US$21m in 2027. Therefore, the company is expected to breakeven just over
Show less
Read more
Impact Snapshot
Event Time:
GKOS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GKOS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GKOS alerts
High impacting Glaukos Corporation news events
Weekly update
A roundup of the hottest topics
GKOS
News
- Glaukos (NYSE:GKOS) had its "buy" rating reaffirmed by analysts at The Goldman Sachs Group, Inc..MarketBeat
- Glaukos price target raised to $145 from $115 at Stephens [Yahoo! Finance]Yahoo! Finance
- Glaukos (NYSE:GKOS) had its "overweight" rating reaffirmed by analysts at Stephens.MarketBeat
- Glaukos (NYSE:GKOS) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $116.00 price target on the stock.MarketBeat
- Is Huntsville Alabama's boomtown? Check out 2025's top 6 economic stories for your answer [Yahoo! Finance]Yahoo! Finance
GKOS
Earnings
- 10/29/25 - Beat
GKOS
Sec Filings
- 1/8/26 - Form 144
- 1/7/26 - Form 4
- 1/7/26 - Form 4
- GKOS's page on the SEC website